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The cell-surface antigen GIx is expressed on the thymocytes of certain strains of
mice and not on the thymocytes of others (1). Its inheritance has been studied
most extensively in crosses of the GIx+ strain 129 with C57BL/6 (B6)' and other
G,- strains. Its expression has been shown to depend, in 129 mice, on genes at
two loci, on chromosomes 7 and 17 (1, 2) . In company with other T-lymphocyte
surface components (TL, Ly-1, etc.) expression of G, x depends on the T-lym-
phocyte pathway of differentiation (3, 4) and it does not occur on other cells (with
the single exception of sperm, on which G,x has been found by serological
absorption, although no comprehensive study of G, x representation on sperm has
yet been made). By the usual methods of serial backcrossing, the G,x phenotypes
of 129 and B6 have been interchanged to produce two congenic lines of mice:
129/G,x- and B6/GIx+ (1).
An indication that the G, x+ character of 129 mouse thymocytes represents
partial expression of murine leukemia virus (MuLV) genome comes from the fact
that cells producing MuLV may express G, X on their surfaces regardless of their
tissue type and of their inherited G, x genotype, which normally controls expres-
Sion us. nonexpression as outlined above. In other words, cells producing MuLV
frequently express GIX regardless of their differentiative history and hereditary,
whereas in the absence of virus production GIX behaves as a thymocyte differen-
tiation alloantigen (4, 5).
It is understandable therefore that in mice that are lifelong overt producers of
MuLV, like AKR, the tissue representation of G, x is more widespread than in 129
mice, and that its expression is governed to a large extent by loci regulating the
output of virus: Aku-1, Aku-2 (6), and Fu-1 (7), as is clearfrom another study (H .
Ikeda, unpublished results) . It is understandable also that on the cells of rats
inoculated with MuLV, and on the leukemias thus induced in the rat, G,x
cell-surface antigen is expressed. In fact, the serological reaction used to
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Abbreuiations used in this paper: anti-NTD, (W/Fu x BN)F, rat anti-MuLV-induced W/Fu rat
leukemia (C58NT)D; B6, C57BL/6; FMR, type antigen of the Friend-Moloney-Rauscher set of
viruses; gs, group specific; IFA, immunofluorescence absorption; MuLV, murine leukemia virus.
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demonstrate and analyze the Gix system is the complement-dependent lysis of
129 thymocytes (cytotoxicity assay) by antibody produced in inbred rats against
syngeneic MuLV-induced rat leukemia cells (1, 8) . Antibodies directed to other
MuLV-associated antigens, which this antiserum contains, do not compromise
this Gix cytotoxicity assay because no such known antigens are expressed on the
129 thymocyte surface (8).
The induction of G, antigen on infected rat cells in particular suggests that it
might be coded by the MuLV genome, and might in fact represent a constituent
of MuLV that is also a constituent of the thymocyte plasma membrane of certain
mice, independent of complete virus production ; in the latter circumstances its
expression is seen to depend on the differentiative controls of the T-lymphocyte
pathway. The following serological evidence now points to the correctness of this




In 1970, a shipment of C57BR/cdJ mice from theJackson Laboratory, Bar
Harbor, Maine, was found to include mice of both G, x- and G,x+ phenotypes . Our present C57BR
(G,x-) and C57BR/G, x' substrains were derived by selective breeding of typed mice of this group.
The two substrains are skin-graft compatible with each other, and identical for all cell-surface
alloantigens tested.
In 1973, a mouse of our B6 (G,x-) colony, used as a serological control, was found to be G, x'. The
inheritance of this mutation (using "mutation" in itsbroadest connotation) wastraced back through
the pedigree, and our present B6 and B6/G,x+M substrains were established by selective breeding of
typed G,x- and G,x+ mice. These two substrains are skin-graft compatible and are identical for the
following serological and biochemical markers: Dip-1, Id-1 (chromosome 1), Gpd-1, Mup-1
(chromosome 4), Ly-2, Ly-3, Ldr-1 (chromosome 6), Gpi-1, Hbb (chromosome 7), Es-1 (chromosome
8), Thy-1, Mod-1 (chromosome 9), Es-3 (chromosome 11), H-2, Tla (chromosome 17), Ly-1, Pgm-1
(chromosome 19), Pca (chromosome ?), and kidney catalase (chromosome ?) .
Antisera. (a) The antiserum (W/Fu x BN)F, rat anti-MuLV-induced W/Fu rat leukemia
(C58NT)D (8) (abbreviated "anti-NTD") contains antibodies to several MuLV-associated antigens
in addition to G,x. When referred to as "G,x antiserum" it is implied that the antiserum is being
employed in the cytotoxicity assay with thymocytes of strain 129 mice (1), which express on their
surfaces only this antigen (G,,,) among the set of known MuLV antigens (for technical reasons,
thymocytes of B6/G,,+ congenic mice were often substituted for129 thymocytes, with which they are
precisely equivalent in thecontext of G, xtyping) . The endpoint dilution of the anti-NTD serumused
in this study (<50% thymocytes lysed) was 1/800.
(b) Anti-gp69/71 and anti-p30; thegoat and rabbit antisera to the gp69/71 and p30 components of
MuLV-Rauscher, isolated by phosphocellulose chromatography and Sephedex gelfiltration (10) were
kindly provided by Doctors M. Strand and J. T. August (Department of Molecular Biology, Albert
Einstein College of Medicine, Bronx, N. Y.).
Complement (C)-dependent Cytotoxicity Assay for G, x Antigen.
￿
The method of Stockert et al.
(1) was used. Thymocyes of 129 mice (5 x 108/ml) were added in equal volumes to anti-NTD serum
(serial dilutions) andrabbit serum (C source; required dilution predetermined) . Afterincubating for
45 min at 37°C cell viability counts were made in the presence of trypan blue .
Test for Free G,X Antigen in Normal Mouse Serum by Inhibition of the G, Cytotoxicity
Assay. Sera from selected mouse strains were preabsorbed with BALB/c thymocytes to remove
naturally occurring autoantibody to thymocytes (11) which would interfere with the cytotoxicity
assay for G,x antigen.
This preabsorbed serum (25 tul; serial dilutions) was mixed with an equal volume of a prede-
termined dilution of anti-NTD serum (usually 1/200) and incubated for 30 min on ice. Then 50
,ul of thymocytes (5 x 108/ml) were added and incubation continued for 30 min on ice. The cells were190
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washed once and resuspended in 100 A1 of C and incubated for 30 min at 37°C, followed by the usual
viability counts .
Immunofluorescence Absorption (IFA) Test for gp69/71 Antigen.
￿
Themethod used was based on
the method of Hilgers et al. (12) . The standard test cells were E,?G2 leukemia cells (transplanted B6
leukemia induced by passage A Gross virus) acetone fixed on slides. Goat and rabbit anti-gp69/71
serum give bright diffuse cytoplasmic staining in the indirect immunofluorescence test (titers in the
region of 1/1,280 and 1/320, respectively) . Soluble or particulate material is tested for the presence of
'group-specific (gs) antigen of gp69/71 by measuring its capacity to absorb this immunofluorescence
reactivity of anti-gp69/71 serum, used at a predetermined critical dilution (in the region of 1/400)
under standard conditions (13) .
Blocking Test for Proximity of Cell Surface Antigens (14) .
￿
In general terms, the test consists in
the construction of absorption curves. For each curve, different numbersof cells (abscissa) are used to
absorb standard volumes of an antiserum "anti-x" and plotted against the percentage of "x-positive"
target cells lysed in the cytotoxicity assay by any remaining antibody (ordinate) .
The cells used for absorption carry two antigens, "x" and "y," whose proximity is to be studied.
Absorption curves are constructed for these cells after preliminary saturation with "anti-y," and for
control purposes "anti-z," etc. In the case where x and y are adjacent, the absorption curve for x is
selectively displaced by pre-exposure of the cells to anti-y. In the present study, anti-x -- G,x
antiserum, and anti-y =- gp69/71 antiserum.
Test for Absorption of G, Antibody by MuLV.
￿
MuLV "AKR-3T3" virus (lot number 346-59-12)
was purchased from Electro-Nucleonics Laboratories, Inc., Bethesda, Md. This virus stock is de-
scribed as derived from NIH/3T3 cells from NIH Swiss embryo cultures infected with AKR-MuLV,
purified by double density gradient zonal centrifugation . Before use, the virus was pelleted and sus-
pended in phosphate-buffered saline.
Equal volumes of virus suspensions (serial dilutions) and antibody diluted to the vicinity of the
endpoint of the cytotoxicity assay were incubated for 15 min at 37°C, followed by 30 min on ice. After
removal of the virus by centrifugation for 30 min at 110,000 g, 50 Al of the supernate was mixed with
50 Al of thymocytes (5 x 106/ml). The absorption procedure was then completed as described above.
Results and Discussion
One of the two major components of the MuLV envelope is gp69/71, comprising a
pair of glycoproteins with mot wt of 69,000 and 71,000 and possessing common
antigens, which can be isolated from disrupted virus (10) . Antibody to purified
gp69/71, made in goat or rabbit, identifies gp69/71 antigens in fixed virus-pro-
ducing cells in the indirect immunofluorescence test (13) ; the presence of MuLV
gp69/71 in any material can be assayed by absorption of this immunofluores-
cence reactivity from gp69/71 antiserum in the IFA test. As Table I shows: (a)
Free gp69/71 antigen is demonstrable by the IFA test in the serum of mice of
several strains (as reported by Yoshiki et al. [l5] for the NZB strain), including
not only overt life long virus producers like AKR and C58, but also 129 and
several other mouse strains. (b) Mouse strains with gp69/71 antigen in their
serum express Gix on their thymocytes in the cytotoxicity assay. (c) This
concordance is not fortuitous, because it includes the congenic partners of B6,
129, and C57BR, which have similar genetic backgrounds but differ in their G,
thymocyte phenotype.
A new observation, illustrated in Fig. 1, is that G1 , antigen also can be
demonstrated free in the serum of 129 mice ; this is shown by the capacity of 129
normal serum to inhibit the cytotoxicity of G, antibody for 129 thymocytes . The
concentration of'G,, antigen in the serum increases substantially within the age
range of 3-15 wk, as Fig. I also illustrates, although the concentration of G, xY. OBATA, H. IKEDA, E. STOCKERT, AND E. A. BOYSE
TABLE I
Concordance of Tests for G,x and gp69/71 Antigens in the Serum of Various
Mouse Strains
Mousestrain (age approximately 2 mo)
129, B6/G,x+, B6/G, x+M, C57BR/G,x+ (see congenic
partners below); and also CE, AKR, C58, I, DBA/2, A,
SJL/J, C3H/An
129/G,x-, 136, C57BR (see congenic partners above) ; and
also C57L, BALB/c
* C-dependent cytotoxicity assay.
$Inhibition test for G,X antigen.


























Detection of free G,x antigen in the serum of 129 mice of various ages by inhibition of
the G, x cytotoxicity assay. Control: serum of 129/G,x - mice (25 wk old) . (*), age of mice
donating serum (pool from sets of three female mice).
antigen on thymocytes shows no similar change in 129 mice (Kohei Kawashima,
personal communication) . Table I shows that the presence of Gcx antigen in
serum correlates with its presence on thymocytes, and with the presence of
gp69/71 antigen in the serum ; i .e . if the thymocytes of a mouse strain express G, x
on their surfaces, then both G, x and gp69/71 antigens are demonstrable in the
serum. This also held true in the genetic segregation test illustrated in Table II,192 G,,, ANTIGEN AND MuLV ENVELOPE GLYCOPROTEIN
TABLE 11
Concordance of Tests for (a) G,XAntigen on Thymocytes and (b)
gp69/71 Antigen in the Serum of Backcross* Segregant Mice
* C57BR/G;+ x (C57BR/G,x+ x C57BR)F,.
$ ++, same high reactivity as C57BR/G,X + .
§ +, same low reactivity as (C57BR/G,x+ x C57BR)F,.
in which the presence or absence of G,x on thymocytes was invariably correlated
with presence or absence of gp69/71 antigen in the serum.
It should be emphasized that although soluble MuLV-related antigens (Friend-
Moloney-Rauscher antigen [FMR] and Gross soluble antigen [GSA]) have previ-
ously been demonstrated free in serum (16, 17) this has been so only in mice
producing large quantities ofvirus, whereas in the case of G,x the serum antigen
is seen to be independent of viral output . The fact that the positive G,
phenotype (for thymocytes and serum) correlates with the presence of gp69/71
antigen in serum does not disclose whether G,, and gp69/71 antigens occur on a
single molecule or as separate but codependent products.
To test this, we ascertained whether removal of the gp69/71 component from
129 mouse serum by complexing it with gp69/71 antibody would entail the
removal of G,x antigen also. Once again, as shown in Table III, G,x antigen was
not separable from gp69/71 antigen, i.e., G, x antigen was coprecipitated with
gp69/71 by goat antiserum to gp69/71 MuLV-Rauscher. Among the control
antisera included in Table III is goat antibody to MuLV-Rauscher p30, a major
internal component of the virus (18), which did not coprecipitate G,x.
Although G1x antigen was thus genetically and physically inseparable from
gp69/71 in the serum of all mice tested this does not imply that gp69/71 from all
mouse sources necessarily carries the G, x specificity. The type specificity
recognized on MuLV gp69/71 by radioimmunoassay (19), points to structural
polymorphisms of this component of MuLV. In fact polymorphism of gp69/71
may well be responsible for most of the polymorphism of envelope antigens
revealed by immunoelectron-microscopic studies of MuLV (20). This variation
may extend to the G,x-determining region of the molecule, giving rise to gp69/71
molecules that are G, x+ and others that are Gtx-.
It seems somewhat less likely that Gtx would be expressed on cell surfaces
independently of the rest of the gp69/71 molecule bearing other antigens. But
even this bears consideration, because gp69/71 is a composite molecule (glycopro-
tein) and it is not yet known which moieties account for any of its several
antigens. Cell surface proteins are characteristically glycoproteins, although in
only few instances is there evidence as to what part ofthe molecule is involved in
antigenic variation. In the case of H-2, the alloantigenic differences are most














Precipitation of G; Antigen from 129 Mouse Serum by Goat Antiserum to
gp69/71
*Antiserum (column 1), and undiluted mouse serum from 129 or 129/G, X- mice
(column 2) were mixed in equal volumes (37°C/30 min), centrifuged to remove
antigen-antibody complexes (110,000 g/30 min), and the supernate tested for residual
G, X and gp69/71 antigens .
f Inhibition of G,x cytotoxic antibody.
§ IFA test with rabbit anti-gp69/71 serum.
moiety (21) . The same question arises in connection with each antigen of
gp69/71, the complete synthesis of which must involve more than one gene, in
order to account for its composite structure. Clearly, future study of the chemical
composition of this molecule in relation to GIx and its other antigens will help in
understanding the genetics of its specification, especially on the thymocytes of
129 and other mice where its expression is evidently independent of complete
viral synthesis, and where the joint action of two unlinked chromosomal loci has
already been implicated .
As yet, such detailed analysis is distant, but the following data support the
view that the concordance of GIx expression on thymocytes with presence of
GIx-gp69/71 in the serum is explicable in terms of a single glycoprotein that
resides in the plasma membrane and can be released from it. Since the goat
anti-gp69/71 serum identifies a particular segment or segments of the gp69/71
glycoprotein, and since GIx is apparently a part of the same glycoprotein, goat
anti-gp69/71 might be expected to react with thymocytes of 129 mice, provided
that a relevant segment of gp69/71 is accessible in the plasma membrane. In fact
this antiserum gave a weak but consistent reaction in the cytotoxicity assay with
129 thymocytes but not with 129/GIx - thymocytes.
A plausible reason for the weakness of this cytotoxic reaction on 129
thymocytes is that the gs antigen of gp69/71, to which the gp69/71 antiserum is
directed in reactions with non-Rauscher-MuLV gp69/71, is relatively inacessible
on intact thymocytes. This interpretation is reinforced by tests we have made in
which Nonidet P-40 lysates of 129 thymocytes, but not equivalent numbers of
intact 129 thymocytes (nor lysates of 129/GIx- thymocytes), absorbed anti-
gp69/71 antibody in the IFA assay . 2
2 The type-specific reactivity of the antiserum to gp69/71-Rauscher would not be involved in









- 129 + +
goat anti-gp69/71 (1/30) 129 - -
normal goat serum (1/20) 129 + +
goat anti-p30 (1/20) 129 + +
- 129/G, X- _
goat anti-gp69/71 (1/30) 129/G 1x - -194
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The physical association of the GIx and gp69/71 antigens implies that they
should be situated close together on the thymocyte membrane. In investigating
such questions of proximity we have previously shown that when a particular set
of cell-surface antigens is saturated by the relevant antibody, subsequent ab-
sorption of antibody to a second set of antigens may be impeded, while at the
same time antibody to a third set is not impeded; thus, the relative proximities
of antigens on the cell surface have been estimated on the basis of steric interfer-
ence by the competing antibodies (14) .
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FIG. 2. Blocking of G,x antigen sites on 129 thymocytes by pre-exposure to gp69/71
antiserum. Procedure: Equal volumes of G,x antiserum were absorbed with different numbers
of washed 129 thymocytes (abscissa) that had been preincubated with goat anti-gp69/71 or
other (control) antisera as indicated; after removal of the cells by centrifugation, the absorbed
antiserum wastested for residual G,x antibody in the cytotoxicity assay (ordinate). An index of
the degree of interference between the two antibodies competing for the respective adjacent
sites, G,xand gp69/71, is given by [(a-b)/a] x 100 = [(11.2 - 6.6)/11.2] x 100 = 41% (14).
with p30 antibody, blocks the attachment of GIx antibody to the extent of
approximately 41%, indicating that gp69/71 antiserum identifies a gp69/71
component present on 129 thymocytes, and that this is adjacent to GIx antigen.
The fact that blocking was not complete can be interpreted most readily in terms
of accessibility of membrane-associated gp69/71 antigen (as discussed above), or
in terms of two gp69/71 antigenic sites that are sufficiently widely spaced on the
cell surface to accommodate both the respective antibodies to some degree .
Finally the question arises: Is the GIx section of the gp69/71 molecule
accessible to antibody when gp69/71 composes part of the virion coat rather than
part of the plasma membrane? If so, then intact virus should be capable ofY. OBATA, H . IKEDA, E. STOCKERT, AND E . A. BOYSE
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absorbing GIx antibody. Table IV shows that intact MuLV does in fact absorb
anti-GIx activity in the GIx cytotoxicity assay, and the controls indicate that this
is unlikely to be due to contamination of the virus preparation with G,bearing
fragments of plasma membrane or to the serological artifact of ant.icomplemen-
tarity .
In further tests, the absorption capacity of MuLV frozen once (for storage) was
compared with that of the same MuLV after 10 cycles of freezing and thawing.
The results indicate no increase in availability of viral GIx antigen consequent
upon disruption of virions.
We conclude that G,x antigen is accessible on the intact virion, as it is on the
cell surface. In this respect, GIx antigen differs from FMR (MuLV associated)
antigen. The latter is also a prominent surface antigen of infected cells (23),
TABLE IV
Absorption of G, Cytotoxic Antibody by Purified MuLV
Equalvolumesof antiserum andvirus suspension were mixed andincubated(absorption step), virus
was removed by centrifugation, andthe supernate (absorbed antiserum) tested for residual antibody
(cytotoxicity assay) ; see Materials and Methods.
* Control for contamination of virus preparation with plasma membranes of the cells that produced
the virus (NIH/3T3).
$Control for anticomplementarity of the virus preparation; an anti-Ly system was selected because
Ly-systems are high in demand for C (rabbit) and therefore sensitive indicators of anticomplemen-
tary effects (22) .
recognized similarly by the cytotoxicity assay, but according to Lilly and Steeves
(24) its demonstrability in virions is greatly increased by their disruption,
suggesting that although it is accessible on the cell surface it is internally
situated in the virion.
As discussed above, we do not assume that all variants of the murine gp69/71
molecule carry GIx antigen. Further evidence on this point is now being sought.
Summary
Expression of G, x surfaceantigen on thymocytes is an inherited mendelian trait
of certain strains of mice. We report here the following new findings : (a) GIxanti-
gen was found free in the serum of GIx+ mouse strains. (b) Expression vs.
nonexpression of GIx antigen was invariably correlated with presence or absence
of the group-specific antigen of Murine leukemia virus (MuLV) gp69/71 in the
Residual cytotoxicity afterabsorption
Antiserum (dilution) Target cells
with the following
of virus (jug/ml) :
concentrations
400 200 100 50 25 None
cellslysed %
Anti-G,x (1/200) B6/G,x+ thymocytes 10 27 66 72 84 86
Rabbit antimousecells NIH Swisslymphocytes 90 90
(1/50)*
Anti-Ly-2.2 (1/200)$ B6/G,x' thymocytes 78 79196
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serum of mice of inbred and segregating populations. (c) G,x antigen could be
removed from normal G,x+ mouse serum by precipitation with antiserum to
MuLV gp69/71 . (d) Anti-gp69/71 serum was weakly cytotoxic for G,X+ thymo-
cytes, and partially blocked the cytotoxic activity of G,x antibody for G,x+
thymocytes . (e) Purified AKR virus absorbed G, activity, and disruption of the
virions did not increase their absorbing capacity .
These serological data indicate that G,x antigen is a constituent of gp69/71, the
glycoprotein which is the major component of the MuLV envelope. On present
evidence, G,x antigen is represented in intact virions and is probably accessible
to G,x antibody .
We are indebted to Dr. L. J. Old for helpful discussions, to Dr. H. A. Hoffman (Laboratory ofBiology,
National Cancer Institute, NIH, Bethesda, Md.) for typing our B6 and B6/G,X+M mice for
biochemical markers, and to Doctors M . Strand and J . T. August (Department of Molecular Biology,
Albert Einstein College of Medicine, Bronx, N. Y.) for supplying the anti-gp69/71 and anti-p30 sera.
In addition we thank Mr. Z ., A. Zayas for his contribution to the derivation and maintenance of the
special mouse stocks.
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